1-8 of 8
Matthias Karrasch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results

Clinical Trials & Observations
Nicole Dastugue, Stefan Suciu, Geneviève Plat, Frank Speleman, Hélène Cavé, Sandrine Girard, Marleen Bakkus, Marie Pierre Pagès, Karima Yakouben, Brigitte Nelken, Anne Uyttebroeck, Carine Gervais, Patrick Lutz, Manuel R. Teixeira, Pierre Heimann, Alice Ferster, Pierre Rohrlich, Marie Agnès Collonge, Martine Munzer, Isabelle Luquet, Patrick Boutard, Nicolas Sirvent, Matthias Karrasch, Yves Bertrand, Yves Benoit
Journal: Blood
Blood (2013) 121 (13): 2415–2423.
https://doi.org/10.1182/blood-2012-06-437681
Published: 2013
Includes: Supplemental data
Journal Articles

High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD-AraC) During Induction and IL-2 Vs Observation After Consolidation/Autologous Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia (AML): Final Report of the AML-12 Trial of EORTC and GIMEMA Leukemia Groups on the Value of High Dose AraC

Roelof Willemze, MD, PhD, Stefan Suciu, Franco Mandelli, MD, Giovanna Meloni, Boris Labar, Stijn J.M. Halkes, Petra Muus, MD, PhD, Martin Mistrik, MD, PhD, Giorgina Specchia, Francesco Fabbiano, MD, Francesco Nobile, MD, Marco Sborgia, Andrea Camera, Dominik Selleslag, Francois Lefrere, Domenico Magro, MD, Giuseppe Leone, Nicola Cantore, Meral Beksac, MD, Zwi Berneman, Xavier Thomas, Lorella Melillo, Dominique Bron, Georges Fillet, Jose E. Guimaraes, MD, PhD, Sergio Amadori, Paola Fazi, Matthias Karrasch, Marco Vignetti, Theo de Witte, Jean-Pierre Marie, MD
Journal: Blood
Blood (2011) 118 (21): 257.
https://doi.org/10.1182/blood.V118.21.257.257
Published: 2011
Journal Articles

Clofarabine in Combination with a Standard Remission Induction Regimen (AraC and idarubicin) in Patients with Previously Untreated Intermediate and Bad Risk Acute Myelogenous Leukemia (AML) or High Risk Myelodysplasia (MDS):Phase I Results of An Ongoing Phase I/II Study of the EORTC-LG and GIMEMA(EORTC GIMEMA 06061/AML-14A trial)

Roelof Willemze, MD, PhD, Petra Muus, MD, PhD, Stijn J.M. Halkes, Giovanna Meloni, MD, Stefan Suciu, Liv Meert, Jocelyne Flament, Matthias Karrasch, Marco Vignetti, Sergio Amadori, MD, Theo M. de Witte, MD, Jean-Pierre Marie, MD
Journal: Blood
Blood (2011) 118 (21): 2610.
https://doi.org/10.1182/blood.V118.21.2610.2610
Published: 2011
Journal Articles

Similar Efficacy and Toxicity Profile for Idarubicine and Mitoxantrone in Induction and Intensification Treatment of Children with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS): Long-Term Results of the EORTC-CLG Randomized Phase III Trial 58921

Barbara De Moerloose, Stefan Suciu, Martine Munzer, Caroline Piette, Karima Yakouben, Genevieve Margueritte, Patrick Lutz, Anne Uyttebroeck, Pierre Rohrlich, MD, PhD, Alina Ferster, Patrick Boutard, Marie-Françoise Dresse, Xavier Rialland, Lucilia Norton, Nicolas Sirvent, Matthias Karrasch, Yves Benoit, MD, Yves Bertrand
Journal: Blood
Blood (2011) 118 (21): 2615.
https://doi.org/10.1182/blood.V118.21.2615.2615
Published: 2011
Journal Articles

High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD-AraC) During Induction and IL-2 Vs Observation After Consolidation/Autologous Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia (AML): Final Report of the AML-12 Trial of EORTC and GIMEMA Leukemia Groups on the Value of Low Dose IL-2 Maintenance,

Roelof Willemze, MD, PhD, Stefan Suciu, Franco Mandelli, MD, Stijn J.M. Halkes, Jean-Pierre Marie, Boris Labar, Adriano Venditti, M.D., Petra Muus, MD, PhD, Martin Mistrik, MD, PhD, Andrea Camera, Domenico Magro, MD, Lorella Melillo, Dominique Bron, Silvana Magrin, Dominik Selleslag, Domenico Pastore, Silvia Trisolini, Paola Fazi, Matthias Karrasch, Marco Vignetti, Sergio Amadori, MD, Theo M. de Witte, MD, Giovanna Meloni, MD
Journal: Blood
Blood (2011) 118 (21): 3612.
https://doi.org/10.1182/blood.V118.21.3612.3612
Published: 2011
Journal Articles

In Childhood B-Lineage Acute Lymphoblastic Leukemia (B-ALL) with Hyperdiploidy >50 Chromosomes, Patients with 58 to 66 Chromosomes Have 99% EFS At 6-Year Follow-up: Results of the EORTC CLG 58951 Trial

Nicole Dastugue, Stefan Suciu, Geneviève Plat, Frank Speleman, PhD, Hélène Cavé, Sandrine Girard, Emmanuelle Delabesse, Marie Pierre Pagès, Karima Yakouben, Brigitte Nelken, Francoise Mazingue, MD, Anne Hagemeijer, Anne Uyttebroeck, Carine Gervais, MD, Patrick Lutz, Manuel Teixera, Lucilia Norton, Pierre Heimann, Alina Ferster, Ghislaine Plessis, Patrick Boutard, Marie Agnès Collonge, Pierre Rohrlich, MD, PhD, Isabelle Luquet, MD, PhD, Martine Munzer, Nicolas Sirvent, Dominique Plantaz, Christian Herens, Claire Hoyoux, Matthias Karrasch, Yves Bertrand, Yves Benoit, MD
Journal: Blood
Blood (2011) 118 (21): 565.
https://doi.org/10.1182/blood.V118.21.565.565
Published: 2011
Journal Articles

EORTC 21012: Phase II Multicentre Study of Caelyx™ Monotherapy In Patients with Advanced Mycosis Fungoides Stage IIb, Iva and IVb with or without Previous Chemotherapy.

Reinhard Dummer, Sean Whittaker, Baktiar Hasan, Juergen C Becker, Michael Weichenthal, Rudolf Stadler, Matthias Karrasch, Martine Bagot, Robert Knobler, Maria Bernengo
Journal: Blood
Blood (2010) 116 (21): 2823.
https://doi.org/10.1182/blood.V116.21.2823.2823
Published: 2010
Journal Articles

The EORTC Cutaneous T-Cell Lymphoma (CTCL) Platform

Sean Whittaker, Robert Knobler, Pablo Luis Ortiz-Romero, Maarten Vermeer, Matthias Karrasch, Baktiar Hasan, Stefan Suciu, PhD, Denis Lacombe, Martine Bagot
Journal: Blood
Blood (2010) 116 (21): 4896.
https://doi.org/10.1182/blood.V116.21.4896.4896
Published: 2010